FDA Extends Review for Lipocine's TLANDO; Advisory Committee Meeting Date of January 10, 2018 Rem… Post author:Sam Post published:November 16, 2017 Post category:BioPharma The FDA has assigned a new Prescription Drug User Fee Act goal date of May 8, 2018. Source: BioSpace You Might Also Like AbbVie and Voyager Therapeutics Launch $1.2 Billion+ Alzheimer’s Partnership February 19, 2018 Catastrophic Year for Bay Area's OncoMed Continues as Lead Drug Comes Crashing Down in Phase II Study May 7, 2017 Array BioPharma Slaps $192M Lawsuit on AstraZeneca Over Cancer Drug Royalties February 1, 2018
Catastrophic Year for Bay Area's OncoMed Continues as Lead Drug Comes Crashing Down in Phase II Study May 7, 2017
